Jerry Bryant
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- Viral-associated cancers and disorders
- Peptidase Inhibition and Analysis
Papers in
-
- Glycosylation and Glycoproteins Research 4
- RNA modifications and cancer 2
-
- Radiopharmaceutical Chemistry and Applications 8
- Medical Imaging Techniques and Applications 4
- Co-authors
- David J. Yang (13 shared papers)Dongfang Yu (8 shared papers)Ali Azhdarinia (10 shared papers)Donald A. Podoloff (7 shared papers)Chang‐Sok Oh (4 shared papers)Naomi R. Schechter (3 shared papers)Jonathan King (1 shared paper)E. Edmund Kim (1 shared paper)
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (3 papers)Anti-Cancer Drugs (2 papers)Pharmaceutical Research (2 papers)Blood (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSwedenChina
In The Last Decade
Jerry Bryant
24 papers receiving 573 citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 209
- Oncology 173
- Cancer Research 86
- Pathology and Forensic Medicine 76
- Biochemistry 29
Countries citing papers authored by Jerry Bryant
This map shows the geographic impact of Jerry Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Bryant more than expected).
Fields of papers citing papers by Jerry Bryant
This network shows the impact of papers produced by Jerry Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Bryant. The network helps show where Jerry Bryant may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerry Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 116 | |
| 2 | 1995 | 88 | |
| 3 | 1993 | 43 | |
| 4 | 1992 | 39 | |
| 5 | 2002 | 37 | |
| 6 | 2004 | 33 | |
| 7 | 2003 | 33 | |
| 8 | 2005 | 27 | |
| 9 | 2004 | 25 | |
| 10 | 2016 | 25 | |
| 11 | 1984 | 24 | |
| 12 | 2005 | 15 | |
| 13 | 2012 | 15 | |
| 14 | 1995 | 14 | |
| 15 | 2000 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2018 | 8 | |
| 18 | 2004 | 7 | |
| 19 | 2012 | 6 | |
| 20 | 1995 | 4 |
About Jerry Bryant
Jerry Bryant is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 24 papers that have together received 589 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Medical Imaging and Pathology Studies (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Medical Imaging Techniques and Applications (4 papers), Glycosylation and Glycoproteins Research (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (209 citations), Oncology (173 citations), Cancer Research (86 citations), Pathology and Forensic Medicine (76 citations) and Biochemistry (29 citations). Jerry Bryant has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include David J. Yang, Dongfang Yu, Ali Azhdarinia, Donald A. Podoloff, Chang‐Sok Oh, Naomi R. Schechter, Jonathan King, E. Edmund Kim, Payal Mehta and Richard Mendez. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, Anti-Cancer Drugs, Pharmaceutical Research, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.